Date updated:11-01-2006
Here is a portfolio of stem cell stocks that could be interesting depending on which party wins in the mid term elections.

-
GERN
Geron Corporation - $5.48
- +0.37%
- $5.39
Geron Corporation operates as a biopharmaceutical company and intends to use human embryonic stem cell technology to enable the development of transplantation therapies by providing starting material for the manufacture of cells and tissues.

-
ASTM
Aastrom Bioscienc - $0.31
- -3.12%
- $0.3166
Aastrom Biosciences, Inc., a development stage company, focuses on the development of autologous cell products for use in regenerative medicine.

-
STEM
Stemcells - $1.13
- -0.88%
- $1.13
StemCells, Inc., a biopharmaceutical company, engages in the discovery and development of adult stem cell therapeutics to treat damage to; or degeneration of major organ systems, such as the central nervous system, liver, and pancreas.

-
VIAC
Viac - $0.00
- N/A
- $N/A
ViaCell, Inc., a biotechnology company, engages in the research, development, and commercialization of cellular therapies in the United States and Singapore. It develops a pipeline of proprietary umbilical cord blood-derived and adult-derived stem cell product candidates as treatments for cancer, cardiac disease, and diabetes.

-
ACTC.OB
Advanced Cell Tec - $0.0999
- -0.10%
- $0.0992
Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human stem cell technology in the fields of regenerative medicine and stem cell therapy in the United States.

-
IVGN
N/a - $24.76
- 0.00
- $24.76
Invitrogen Corporation provides products and services that support academic and government research institutions, as well as pharmaceutical and biotechnology companies. The company operates in two segments, BioDiscovery and BioProduction. BioDiscovery segment offers functional genomics, cell biology, and drug discovery product lines. Functional genomics product line includes the research tools used in reagent and kit form for gene acquisition, gene cloning, gene expression, and gene analysis techniques.

-
ALXN
Alexion Pharmaceu - $45.03
- -0.35%
- $44.73
Alexion Pharmaceuticals, Inc., a biotechnology company, together with its subsidiaries, engages in the discovery and development of biologic therapeutic products for the treatment of severe diseases in the United States.

-
LIFC
Lifecell Corporat - $0.00
- 0.00%
- $N/A
LifeCell Corporation engages in the development and marketing of human-derived tissue-based products for use in reconstructive, orthopedic, and urogynecologic surgical procedures to repair soft tissue defects.
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. WisdomTree Intl Consum...
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. i bought into ECLP last thursday. . They
compete with CERNER on putting in big
medical records systems into hospitals.
I believe the industry is going to
consolidate as well.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more
Here is the stock list of some of the largest % losers from Nov. 2, 2009. more
Analyst Downgrades for Nov. 2, 2009. Read more here. more













Comments not available